Evidence Hub

Long non-coding RNAs in cancer

Mi-Young Kim

Non-coding RNA Research, 2019

13 citations

Abstract

It is now well established that long non-coding RNAs (lncRNAs) are key regulators in various biological processes such as development, metabolism and immune response. LncRNAs control these processes via several mechanisms including 1) directing epigenetic modifiers or transcription factors to their target genes, 2) functioning as sponges for endogenous RNAs, 3) regulating mRNA decay, 4) mediating interchromosomal interaction and etc. As a consequence, aberrant expression of lncRNAs is often associated with several diseases including cancer [1]. This special issue “long non-coding RNA in cancer” includes six excellent reviews on recent advances on our understandings of the role for lncRNA in cancer development and progression. First of all, a review by Balas and Johnson discusses general mechanisms by which lncRNAs control cancer pathways and provides a list of lncRNAs that are associated with specific types of cancer. In addition, the authors discuss functions of three lncRNAs including HOTAIR (Hox transcript antisense intergenic RNA), TUG1 (taurine upregulated gene 1) and MEG1 (maternally expressed gene 3) as well as detailed mechanisms of their action in cancer development and progression [2]. In the review by Aird et al., the authors summarize 34 lncRNA that are associated with prostate cancer [3]. Specifically, they emphasize the role for these lncRNAs in the AR (androgen receptor) pathway. In addition, they discuss involvement of lncRNAs in EMT (epithelial to…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free